Publications by authors named "Varun Vellanki"

Article Synopsis
  • - The study investigates the characteristics, treatment patterns, and costs associated with patients diagnosed with Hidradenitis Suppurativa (HS) in the U.S. after the approval of adalimumab, a biologic treatment for the condition.
  • - An analysis of data from over 42,000 patients revealed that common comorbidities include diabetes and chronic pulmonary diseases, with a noted increase in these conditions over time after HS diagnosis.
  • - Most patients were treated with antibiotics; however, surgical procedures were rare, and healthcare costs were considerably high, averaging around $42,143 for adult patients in the two years following their diagnosis.
View Article and Find Full Text PDF